Clovis Oncology acquires rights to FAP-targeted radiopharmaceutical programme from 3B Pharmaceuticals

Image: Clovis Oncology has acquired rights to FAP-targeted radiopharmaceutical programme from 3B Pharmaceuticals. Photo: courtesy of rawpixel from Pixabay.